CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 

Revolution Medicines Inc Accounts Receivables Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics




RVMD Receivables Turnover Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Receivable Change -33.35 % -13.83 % -28.83 % -7.26 % -20.29 %
Y / Y Revenue Change 204.81 % 4.81 % -25.2 % 8.1 % -91.3 %
Receivable Turnover Ratio (TTM) 5.4 4.48 4.25 4.29 4.11
Total Ranking # 2887 # 3328 # 3631 # 3786 # 3476
Average receivable collection period 68 82 86 85 89
Seq. Receivable Change -12.16 % 4.48 % -9.21 % -20.01 % 13.56 %
Seq. Revenue Change -63.19 % 20.3 % -19.89 % 759.22 % -87.34 %


Receivable Turnover Ratio Comment
Revolution Medicines Inc Receivable turnover ratio sequentially improved to 5.4, above company average. Average receivable collection period, for the Revolution Medicines Inc in Sep 30 2022 quarter, has decreased to 68 days, compare to 81 days, in the Jun 30 2022 quarter.

Within Healthcare sector 525 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged compare to previous quarter at no. .

What is Receivable Turnover Ratio?
What is Revolution Medicines Inc Selling?
Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 127
Healthcare Sector # 526
Overall Market # 2887

Receivable Turnover Ratio Statistics
High Average Low
0.08 0.05 0.04
  (Mar 31 2022)





Financial Statements
Revolution Medicines Inc 's Accounts Receivable $ 5 Millions Visit RVMD's Balance sheet
Revolution Medicines Inc 's Sales TTM $ 30 Millions Visit RVMD's Income Statement
Where are RVMD's Sales coming from? Visit RVMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RVMD's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for RVMD's Competitors
Receivables Turnover Ratio for RVMD's Suppliers
Accounts Receivables Turnover Ratio for RVMD's Customers

You may also want to know
RVMD's Growth Rates RVMD's Roa RVMD's Inventory Turnover Ratio RVMD's Dividend Comparisons
RVMD's Profitability Ratios RVMD's Roi RVMD's Asset Turnover Ratio RVMD's Dividend Growth
RVMD's Valuation Ratios RVMD's Roe RVMD's Financial Strength Ratios RVMD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Receivable at quarter ending Sep 30 2022
Ethema Health Corporation   16.39 $ 4.475  Millions$ 0.273  Millions
Rite Aid Corp  15.61 $ 24,209.922  Millions$ 1,550.466  Millions
Nutriband Inc   15.53 $ 1.835  Millions$ 0.118  Millions
Qhslab Inc  15.51 $ 1.305  Millions$ 0.084  Millions
Clubhouse Media Group Inc   15.18 $ 5.905  Millions$ 0.389  Millions
Endonovo Therapeutics Inc   15.04 $ 0.014  Millions$ 0.001  Millions
Cv Sciences Inc   14.99 $ 17.305  Millions$ 1.154  Millions
Regenxbio Inc   14.83 $ 480.034  Millions$ 32.378  Millions
Harrow Health Inc   14.77 $ 88.454  Millions$ 5.991  Millions
Patterson Companies Inc   14.68 $ 6,384.837  Millions$ 434.817  Millions
Neurometrix Inc   14.67 $ 8.229  Millions$ 0.561  Millions
Ngm Biopharmaceuticals Inc   14.44 $ 58.111  Millions$ 4.026  Millions
23andme Holding Co   14.39 $ 297.622  Millions$ 20.686  Millions
Alerislife Inc   14.36 $ 707.966  Millions$ 49.312  Millions
Travere Therapeutics Inc   14.18 $ 213.399  Millions$ 15.049  Millions
Corcept Therapeutics Inc  14.15 $ 397.624  Millions$ 28.095  Millions
Apellis Pharmaceuticals Inc   14.11 $ 113.049  Millions$ 8.011  Millions
Delcath Systems Inc   14.00 $ 4.190  Millions$ 0.299  Millions
Kiniksa Pharmaceuticals Ltd   13.52 $ 177.041  Millions$ 13.098  Millions
Owens and Minor Inc   13.37 $ 9,871.514  Millions$ 738.292  Millions
Emmaus Life Sciences inc   13.16 $ 15.480  Millions$ 1.176  Millions
Nurix Therapeutics Inc.  13.08 $ 39.240  Millions$ 3.000  Millions
Thorne Healthtech Inc   12.56 $ 121.146  Millions$ 9.646  Millions
Myovant Sciences Ltd   12.33 $ 333.323  Millions$ 27.037  Millions
Cvs Health Corporation  12.07 $ 315,225.000  Millions$ 26,108.000  Millions
Marker Therapeutics inc   12.02 $ 6.946  Millions$ 0.578  Millions
Chinook Therapeutics Inc   11.94 $ 56.852  Millions$ 4.761  Millions
Semler Scientific inc   11.93 $ 54.433  Millions$ 4.563  Millions
Merus N v   11.77 $ 45.629  Millions$ 3.875  Millions
Abiomed Inc   11.77 $ 1,074.096  Millions$ 91.284  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HESM's Profile

Stock Price

HESM's Financials

Business Description

Fundamentals

Charts & Quotes

HESM's News

Suppliers

HESM's Competitors

Customers & Markets

Economic Indicators

HESM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071